Pharma & Biotech
Bayer’s Two Faces: Factory Innovation Meets Shareholder Austerity
The contrast at Bayer has rarely been starker. At its Leverkusen headquarters, the company is celebrating a prestigious industry award...
Gerresheimer’s Reckoning: Rejected Buyout, BaFin Scrutiny, and a Race for Credibility
The Düsseldorf-based pharmaceutical packaging group Gerresheimer is navigating one of the most turbulent periods in its history, juggling a spurned...
Evotec’s Strategic Pivot Gains Traction Amid Investor Scrutiny
Evotec SE is navigating a critical transformation, and recent financial moves and market activity suggest the plan is beginning to...
BioNTech’s €17 Billion War Chest Faces Its First Real Test on May 5
The numbers coming out of BioNTech’s pancreatic cancer study are the kind that make oncologists sit up. Seven out of...
Gerresheimer’s Creditors Grant Reprieve as Strategic Overhaul Intensifies
Düsseldorf-based packaging specialist Gerresheimer has secured a crucial financial lifeline from its creditors, buying time to navigate a severe accounting...
BioNTech’s Oncology Ambitions Fuel Rally Ahead of Pivotal Shareholder Vote
A resurgence in biotech sentiment, driven by sector-wide deal speculation and clinical breakthroughs, is providing a powerful tailwind for BioNTech...
ImmunityBio’s Legal and Financial Trajectories Diverge Sharply
ImmunityBio finds itself navigating a stark dichotomy. While its commercial engine, driven by the cancer drug ANKTIVA, is firing on...
Redcare Pharmacy’s Tech-Driven Turnaround Faces a Margin Reality Check
Redcare Pharmacy's stock has clawed back from a March low of 31 euros, now trading around 53 euros, yet it...
Novo Nordisk Navigates Pipeline Promise and Payer Pushback
Novo Nordisk shares, trading near 33 euros, reflect a market grappling with the pharmaceutical giant's dual narrative. While the company...
Gerresheimer’s Creditor Deal and Rejected Bid Frame a Precarious Path Forward
A crucial debt reprieve and a spurned takeover offer have defined the recent trajectory of Gerresheimer, even as the German...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
